PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-16.88%
Negative net income growth while ORCL stands at 31.37%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
11.89%
Some D&A expansion while ORCL is negative at -6.27%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-278.06%
Negative yoy deferred tax while ORCL stands at 163.33%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-1.19%
Negative yoy SBC while ORCL is 3.07%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
1.12%
Slight usage while ORCL is negative at -113.56%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-365.56%
Both yoy AR lines negative, with ORCL at -1251.52%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-20.33%
Both reduce yoy inventory, with ORCL at -96.15%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
86.82%
Lower AP growth vs. ORCL's 1152.86%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
62.24%
Lower 'other working capital' growth vs. ORCL's 161.71%. David Dodd would see fewer unexpected short-term demands on cash.
-5.50%
Negative yoy while ORCL is 47.46%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-18.36%
Negative yoy CFO while ORCL is 7.37%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-15.03%
Negative yoy CapEx while ORCL is 51.09%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
88.73%
Some acquisitions while ORCL is negative at -103.01%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-10.08%
Negative yoy purchasing while ORCL stands at 22.96%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-7.95%
Both yoy lines are negative, with ORCL at -36.07%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-18.18%
Both yoy lines negative, with ORCL at -296.75%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-83.71%
Both yoy lines negative, with ORCL at -63.95%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
97.22%
We repay more while ORCL is negative at -87.50%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
8.81%
Lower share issuance yoy vs. ORCL's 284.57%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
4.67%
Buyback growth below 50% of ORCL's 10.57%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.